CUE vs STZ · rev $13.6M vs P/E 14, rev $1.92B
Cue Biopharma (CUE) versus Constellation Brands Inc Class A (STZ) — a side-by-side from cached financials, not a winner call.
Cue Biopharma (CUE) is a biotechnology company listed on US.
Constellation Brands Inc Class A (STZ) is a beverages - brewers company listed on US.
Latest reported CUE revenue for 2026-06-30 was $13.6M. Net income was -$158.2M. CUE currently screens at market cap $59.5M.
Latest reported STZ revenue for 2026-02-28 was $1.92B. Net income was $201.8M. Revenue was down 11.3% from 2025-02-28 to 2026-02-28. STZ currently screens at market cap $23.73B and trailing P/E 14.4.
CUE currently screens at market cap $59.5M. STZ currently screens at market cap $23.73B and trailing P/E 14.4.
Not investment advice. Open the CUE and STZ stock pages for the full models.
Not investment advice.